Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Graft-versus-host Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Northwell Health, New Hyde Park, New York, United States
Contact: Study coordinator (Kelli Cole) · kcole5@northwell.edu · 516-734-8973
Contact: Study coordinator (Angie Fleury) · AFleury2@northwell.edu · 516-734-8973
Contact: Principal Investigator (A. Samer Al-Homsi, MD, MBA)

Study leads

A. Samer Al-Homsi, MD, MBA
Principal Investigator
Northwell Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Acute Myelogenous Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE2

New York, United States

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Chronic Graft-versus-host Disease (cGVHD)

Abroad (travel likely)RecruitingPHASE2

Miami, United States · Tampa, United States

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Chronic Graft-Versus-Host Disease (cGVHD)

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Los Angeles, United States

A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.

Acute Graft-versus-Host Disease

Abroad (travel likely)RecruitingPHASE1

Tianjin, China